English
Back
Download
Log in to access Online Inquiry
Back to the Top

Watching for FDA response

$Neuraxis (NRXS.US)$ Neuraxis Announces New Submission to the FDA for the Expansion of Its Ib-Stim Label; Provides Compliance With NYSE Guidelines on Audit Disclosure
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2586 Views
Comment
Sign in to post a comment